Last reviewed · How we verify
NCT04266821
Establishing Clinical Utility of a New Diagnostic Test for Patients Suffering From Pain: A CPV® Randomized Controlled Trial
NA trial testing Experimental Arm in Pain in 154 participants. Completed in 31 May 2020.
4 May 2020
Quick facts
| Lead sponsor | Qure Healthcare, LLC |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 154 |
| Start date | 1 February 2020 |
| Primary completion | 4 May 2020 |
| Estimated completion | 31 May 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Experimental Arm
Conditions studied
- Pain — all drugs for Pain →
- Pain, Chronic — all drugs for Pain, Chronic →
Sponsor
Qure Healthcare, LLC — full company profile →
Who can join
Eligibility, any sex, with Pain or Pain, Chronic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will collect high-quality data on how practicing primary care physicians across the U.S. currently manage patients experiencing chronic pain and how the results of Ethos Laboratories' test change clinical decision making. To do so, this study leverages simulated patient cases called Clinical Performance and Value vignettes (CPVs) in a proven methodology to rapidly measure physician care decisions.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Randomized Trial on the Clinical Utility of a Novel Biomarker Panel to Identify Treatable Determinants of Chronic Pain.
Peabody J, Paculdo D, Tamondong-Lachica D, Cabaluna IT, et al · · 2020 · cited 4× · PMID 32717995 · DOI 10.3390/diagnostics10080513
Verify or expand the search:
- PubMed search for NCT04266821
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Experimental Arm
Trials testing the same drug.
- NCT06972719 — Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy · NA · recruiting
- NCT04298866 — White Matter Hyperintensities Subtypes in Cerebral Small Vessel Disease : 7 Tesla Ultra-high Resolution Imaging MRI · NA · unknown
- NCT04266834 — Establishing Clinical Utility of a New Diagnostic Test in Patients Undergoing Cardiac Catheterization · NA · completed
- NCT04204018 — Measuring Practice Pattern Changes and Clinical Utility of a Novel Test for Preeclampsia · NA · completed
Other recruiting trials for Pain
Currently open trials in the same condition.
- NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
- NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
- NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting
Other Qure Healthcare, LLC trials
Trials by the same sponsor.
- NCT07099001 — Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay · NA · completed
- NCT05702385 — Clinical Utility Study for Exo-PDAC · NA · withdrawn
- NCT05603299 — Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for Venn Biosciences' Dawn Test · NA · withdrawn
- NCT05910697 — Clinical Utility of MyProstateScore 2.0 P2 · NA · terminated
- NCT05525806 — Clinical Utility Study for MyProstateScore+ · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04266821 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Qure Healthcare, LLC
- Last refreshed: 16 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04266821.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing